Our commitment: improving health through responsible business
We aim to improve global health. Through our business, we make an important contribution to society: We discover and develop innovative medicines. Novartis collaborates with others to help address some of the world’s greatest health challenges. We focus our corporate responsibility work on two areas that underscore our mission of caring and curing: expanding access to healthcare and doing business responsibly.
We work to control and eliminate diseases such as malaria and leprosy, pioneer new business approaches to reach underserved patients, and find new treatments and adaptive solutions to improve health in developing countries. In 2014, these efforts reached more than 72 million people.
This is a core part of Novartis. We are committed to creating a culture of integrity and demonstrate ethical leadership – because as a global leader in healthcare, we have a responsibility to serve as a role model in how we conduct our business. We also care for our associates, work to positively contribute to our communities, and strive for environmental sustainability.
We strive for high performance with high integrity. In line with this commitment, we operate a company-wide integrity and compliance program. Last year, Novartis associates worldwide completed more than 202 100 e-learning courses in various integrity and compliance topics. Each Novartis division has its own marketing code.
Transparency: Voluntary Disclosure of Payments to Healthcare Professionals and Healthcare Organizations
Novartis Pharmaceuticals Canada Inc. is proud to be part of an initiative to voluntarily disclose our aggregate payments to Canadian healthcare practitioners and healthcare organizations. By bringing greater transparency to our work, we hope to foster stronger understanding of our industry’s collaborations across the healthcare sector, and enhance trust in Canada’s healthcare system.